SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-012611
Filing Date
2010-03-08
Accepted
2010-03-08 08:15:42
Documents
5
Period of Report
2010-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-5295_18k.htm 8-K 28657
2 EX-99.1 a10-5295_1ex99d1.htm EX-99.1 124811
3 EX-99.2 a10-5295_1ex99d2.htm EX-99.2 18245
4 GRAPHIC g52951mpi001.gif GRAPHIC 5046
5 GRAPHIC g52951mni001.gif GRAPHIC 5046
  Complete submission text file 0001104659-10-012611.txt   187598
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 10662388
SIC: 2834 Pharmaceutical Preparations